|
|
| Equipements Ophtalmiques > Etude de marché sectorielle |
| Financial Markets Research: Bausch & Lomb's Contact Lens Solution Withdrawal - ReNu MultiPlus likely to struggle in attempt to regain market share |
|
|
|
|
€ 3 040,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Août 2006 |
Taille du document : |
12 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US State Market Index: Lens blanks, optical
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Lens blanks, optical [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 3 industry firms.
|
475,00 €
|
| |
| |
Ophthalmic Pharmaceutical Drugs
488 pages | Janvier 2007 |
This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ Million.
The major therapeutic categories analyzed are Glaucoma, Anti-allergy, Anti-infective, Dry Eye, Anti-inf |
3 160,00 €
|
| |
| |
Chinese Markets for Eye Care Products
246 pages | Mars 2003 |
China's demand for eye care products has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's econom |
2 835,00 €
|
| |
| |
CONTACT LENSES in France
118 pages | Janvier 2008 |
The Plimsoll Portfolio Analysis - CONTACT LENSES is a comprehensive evaluation of the French market.
The revised and updated 2008 edition analyses the financial performance of each of the companies |
568,00 €
|
| |
| |
Contact Lenses and Solutions
337 pages | Juin 2007 |
This report analyzes the worldwide markets for Contact Lenses and Solutions in Millions of US$.
The major product segments analyzed are Contact Lenses and Contact Lens Care Solutions.
The sub pr |
3 160,00 €
|
| |
| |
Ophthalmic Goods Manufacturing in the US
32 pages | Juillet 2007 |
IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's February 2007 edition of Ophthalmic Goods Manufacturing in the US report.Industry Market Research SynopsisThis Industry |
525,00 €
|
| |
| |
Glassware in Germany
10 pages | Octobre 2005 |
Euromonitor International ’s Glassware in Germany Major Market Profile presents an overview of the national market.
Use this data to quickly establish market sizes and shares, pinpoint growth marke |
198,00 €
|
| |
| |
Glassware in the USA
10 pages | Octobre 2005 |
Euromonitor International ’s Glassware in the USA Major Market Profile presents an overview of the national market.
Use this data to quickly establish market sizes and shares, pinpoint growth marke |
198,00 €
|
| |
| |
Glassware in the UK
15 pages | Septembre 2002 |
The UK glassware market has grown by 0.6% since 2000 to reach a value of £278.1 in 2001.
Over the five year review period value sales increased by 7.8% The hand made glassware variety has suffered |
198,00 €
|
| |
| |
Eyeglasses and contact lenses in the UK
10 pages | Octobre 2005 |
Euromonitor International ’s Eyeglasses and Contact Lenses in the UK Major Market Profile presents an overview of the national market.
Use this data to quickly establish market sizes and shares, pi |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Financial Markets Research: Bausch & Lomb's Contact Lens Solution Withdrawal - ReNu MultiPlus likely to struggle in attempt to regain market share |
|
|
Introduction
In May 2006 Bausch & Lomb's ReNu with MoistureLoc contact lens solution was permanently withdrawn from markets worldwide due to an outbreak of a fungal eye infection. For a large market player, the loss of a new revenue driver and the negative publicity surrounding the event is likely to have a significant impact on future success, as well as implications for other companies in the sector.
Scope
This report analyzes the market outlook in the aftermath of the withdrawal of Bausch & Lomb's ReNu with MoistureLoc contact lens solution
Datamonitor interviewed eight optometrists from the US and the EU in the course of research
Highlights
Bausch & Lomb's explanation of the cause of infection is in line with suspicions of interviewed optometry experts that the revolutionary make-up of MoistureLoc's formula made it susceptible to external factors that could elevate infection risk.
Moving forward, US practitioners will likely put more emphasis on patient adherence to particular recommended brands, and patients are likely to be less price-sensitive, favoring competitors over Bausch & Lomb's older contact lens solution, ReNu MultiPlus.
Collateral damage to Bausch & Lomb's eye care franchise in European markets is expected to be minimal.
Reasons to Purchase
Understand the implications of Bausch & Lomb's product recall through in-depth analysis based on interviews with leading experts
Anticipate likely changes in the future market dynamics for contact lens solutions following the withdrawal of ReNu with MoistureLoc
|
|
Introduction
In May 2006 Bausch & Lomb's ReNu with MoistureLoc contact lens solution was permanently withdrawn from markets worldwide due to an outbreak of a fungal eye infection. For a large market player, the loss of a new revenue driver and the negative publicity surrounding the event is likely to have a significant impact on future success, as well as implications for other companies in the sector.
Scope
This report analyzes the market outlook in the aftermath of the withdrawal of Bausch & Lomb's ReNu with MoistureLoc contact lens solution
Datamonitor interviewed eight optometrists from the US and the EU in the course of research
Highlights
Bausch & Lomb's explanation of the cause of infection is in line with suspicions of interviewed optometry experts that the revolutionary make-up of MoistureLoc's formula made it susceptible to external factors that could elevate infection risk.
Moving forward, US practitioners will likely put more emphasis on patient adherence to particular recommended brands, and patients are likely to be less price-sensitive, favoring competitors over Bausch & Lomb's older contact lens solution, ReNu MultiPlus.
Collateral damage to Bausch & Lomb's eye care franchise in European markets is expected to be minimal.
Reasons to Purchase
Understand the implications of Bausch & Lomb's product recall through in-depth analysis based on interviews with leading experts
Anticipate likely changes in the future market dynamics for contact lens solutions following the withdrawal of ReNu with MoistureLoc
|
|
|
PPLSEN
|
|
|
|
|
